Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
AstraZeneca
Teva
Deloitte
Federal Trade Commission
Express Scripts
US Army
Farmers Insurance
Johnson and Johnson

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200654

« Back to Dashboard

NDA 200654 describes ANASTROZOLE, which is a drug marketed by Accord Hlthcare, Apotex Inc, Cipla Ltd, Dr Reddys Labs Ltd, Fresenius Kabi Oncol, Impax Labs Inc, Kremers Urban Pharms, Mylan, Natco Pharma Ltd, Sandoz, Santos Biotech, Sun Pharm Inds Ltd, Synthon Pharms, Teva Pharms, Watson Labs Teva, West-ward Pharms Int, and Zydus Pharms Usa Inc, and is included in seventeen NDAs. It is available from twenty-nine suppliers. Additional details are available on the ANASTROZOLE profile page.

The generic ingredient in ANASTROZOLE is anastrozole. There are twenty-four drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the anastrozole profile page.
Summary for 200654
Tradename:ANASTROZOLE
Applicant:Apotex Inc
Ingredient:anastrozole
Patents:0
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Pharmacology for NDA: 200654
Mechanism of ActionAromatase Inhibitors
Suppliers and Packaging for NDA: 200654
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANASTROZOLE anastrozole TABLET;ORAL 200654 ANDA Golden State Medical Supply, Inc. 60429-286 N 60429-286-30
ANASTROZOLE anastrozole TABLET;ORAL 200654 ANDA Golden State Medical Supply, Inc. 60429-286 N 60429-286-90

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:May 11, 2012TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
QuintilesIMS
Daiichi Sankyo
Queensland Health
Federal Trade Commission
Boehringer Ingelheim
Harvard Business School
Express Scripts
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.